Jay Siegel
Vermögen: 68 145 $ am 30.06.2026
Vermögen: 68 145 $ am 30.06.2026
Jay Philip Siegel is currently Co-Chairman of the Regenerative Medicine Forum at The National Academies of Science and Chief Biotechnology Officer at Janssen Research & Development LLC.
Former positions include Director at Biotechnology Innovation Organization, Director at Alliance for Regenerative Medicine, Independent Director at MacroGenics, Inc. from 2017 to 2026, and Chief Biotechnology Officer at Johnson & Johnson.
Education includes a doctorate from Stanford University and an undergraduate degree from California Institute of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MACROGENICS, INC. 0.02% | 18.05.2026 | 14’750 ( 0.02% ) | 68 145 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MACROGENICS, INC. | Direktor/Vorstandsmitglied | 19.05.2026 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktor/Vorstandsmitglied | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen